Immune Checkpoint Inhibitor-Related Pneumonitis

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Immune Checkpoint Inhibitor-Related Pneumonitis trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT06860542

Inhaled Budesonide for REcurrence Prevention and Adjuvant THerapy in Checkpoint Inhibitor Pneumonitis

The introduction of immune checkpoint inhibitors (immunotherapy) that stimulate our immune system to recognize and attack cancer cells has been one of the most…

Canada94 participantsStarted 2026-02-10

Treatment: Arm 2- Budesonide (Pulmicort® Turbuhaler®) + Usual care, Arm 1- Usual care

All recent trials (3 shown)

Not Yet RecruitingNot Applicable

NCT07554885

Nutritional Therapy Plus Corticosteroids for Immune Checkpoint Inhibitor-Related Pneumonitis

This is a prospective, single-center, open-label, randomized controlled clinical trial evaluating whether the addition of a nutritional therapy regimen (Spiruli…

China60 participantsStarted 2026-04

Treatment: Spirulina-Bifidobacterium capsule, Fish oil-grape seed-blueberry soft capsule

UnknownNot Applicable

NCT05899725

The Efficacy and Safety of Corticosteroids in Combination With Ruxolitinib in the Management of Checkpoint Inhibitor Pne…

This study is a prospective multicenter randomized controlled Interventional study, to assess the clinical efficacy and safety of corticosteroids compared to co…

China60 participantsStarted 2023-04-14

Treatment: Corticosteroids, Corticosteroids and Ruxolitinib